Report dr reddy s laboratories ltd

Auditors' Responsibility Our responsibility is to express an opinion on these standalone financial statements based on our audit. A company's internal financial control over financial reporting includes those policies and procedures that 1 pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; 2 provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorisations of management and directors of the company; and 3 provide reasonable assurance regarding prevention or timely detection of unauthorised acquisition, use, or disposition of the company's assets that could have a material effect on the financial statements.

The same year, it also became the first non-Japanese pharmaceutical company from the Asia-Pacific region to obtain a New York Stock Exchange listing, ground-breaking achievements for the Indian pharmaceutical industry.

Also, projections of any evaluation of the internal financial controls over financial reporting to future periods are subject to the risk that the internal financial control over financial reporting may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate Opinion In our opinion, the Company has, in all material respects, an adequate internal financial controls system over financial reporting and such internal financial controls over financial reporting were operating effectively as at 31 Marchbased on the internal control over financial reporting criteria established by the Company considering the essential components of internal control stated in the Guidance Note on Audit of Internal Financial Controls Over Financial Reporting issued by ICAI.

Barr Laboratories of the U. Management's Responsibility for the Standalone Financial Statements The Company's Board of Directors is responsible for the matters stated in Section 5 of the Companies Act, "the Act" with respect to the preparation of these standalone financial statements that give a true and fair view of the financial position, financial performance and cash flows of the Company in accordance with the accounting principles generally accepted in India, including the Accounting Standards specified under Section of the Act, read with Rule 7 of the Companies Accounts Rules, It strengthened its Indian manufacturing operations by acquiring American Remedies Ltd.

Meaning of Internal Financial Controls Over Financial Reporting A company's internal financial control over financial reporting is a process Report dr reddy s laboratories ltd to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles.

Reddy's Laboratories Limited "the Company" as of 31 March in conjunction with our audit of the standalone financial statements of the Company for the year ended on that date.

As per the agreement, Dr.

Management's Responsibility for Internal Financial Controls The Company's management is responsible for establishing and maintaining internal financial controls based on the internal control over financial reporting criteria established by the Company considering the essential components of internal control stated in the Guidance Note on Audit of Internal Financial Controls Over Financial Reporting issued by the Institute of Chartered Accountants of India ICAI.

The Company has granted unsecured loans to one company and two body corporates covered in the register maintained under Section of the Companies Act, "the Act". In OctoberDr Reddy?

At that point, Perlecan became a wholly owned subsidiary. In our opinion and according to the information and explanation given to us, the Company is not a Nidhi Company and the Nidhi Rules, are not applicable to it. Opinion In our opinion and to the best of our information and according to the explanations given to us, the aforesaid standalone financial statements give the information required by the Act in the manner so required and give a true and fair view in conformity with the accounting principles generally accepted in India, of the state of affairs of the Company as at 31 March and its profit and its cash flows for the year ended on that date.

Those Standards require that we comply with ethical requirements and plan and perform the audit to obtain reasonable assurance about whether the financial statements are free from material misstatement.

The physical verification of inventory, excluding stocks lying with third parties, have been conducted at reasonable intervals by the Management during the year.

According to the information and explanations given to us, no undisputed Report dr reddy s laboratories ltd payable in respect of provident fund, employees' state insurance, income—tax, sales—tax, wealth tax, service tax, duty of customs, duty of excise, value added tax, cess and other material statutory dues were in arrears as at 31 March for a period of more than six months from the date they became payable.

The procedures selected depend on the auditor's judgement, including the assessment of the risks of material misstatement of the financial statements, whether due to fraud or error.

Reddy's Laboratories has entered into a settlement agreement with Pfizer which will resolve litigation related to Lipitor R Tablets, known generically as Atorvastatin Calcium tablets.

In MarchDr. We conducted our audit in accordance with the Standards on Auditing specified under Section 10 of the Act. At that time the company also became listed on the New York Stock Exchange.

The Company has disclosed the impact of pending litigations on its financial position in its financial statements — Refer Note 2.

Reddy's launches pegfilgrastim in India under the brand name 'Peg—grafeel In —Dr. Therefore, in the absence of stipulation of repayment terms, we don't make any comment on the regularity of repayment of principal and payment of interest. Report on Other Legal and Regulatory Requirements 1.

Accordingly, provisions of clause 3 xii of the Order are not applicable. Auditors' Responsibility Our responsibility is to express an opinion on the Company's internal financial controls over financial reporting based on our audit.

Our audit of internal financial controls over financial reporting included obtaining an understanding of internal financial controls over financial reporting, assessing the risk that a material weakness exists, and testing and evaluating the design and operating effectiveness of internal control based on the assessed risk.

Lilly had numerous other patents surrounding the drug compound and had already enjoyed a long period of patent protection. We have broadly reviewed cost records maintained by the Company pursuant to the Rules prescribed by the Central Government under Section 1 of the Act, and are of the opinion that, prima facie, the prescribed accounts and records have been made and maintained.

During the course of our examination of the books and records of the Company, carried out in accordance with the generally accepted auditing practices in India, and according to the information and explanations given to us, we have neither come across any instance of material fraud by the Company or on the Company by its officers or employees, noticed or reported during the year, nor have we been informed of any such case by the Management.

The Company has made provision, as required under the applicable law or accounting standards, for material foreseeable losses, if any, including derivative contracts; and iii. The combined entity will undertake clinical development and out-licensing of new chemical entity assets.

As per this pact, the duo will be working in the area of pain and inflammation. Reddy's Laboratories Limited "the Company" on the standalone financial statements as of and for the year ended 31 Marchwe report that: Patient-Centric initiatives[ edit ] In SeptemberDr.

The details of such related party transactions have been disclosed in the financial statements as required under Accounting Standard 18, Related Party Disclosures specified under section of the Act, read with Rule 7 of the Companies Accounts Rules, The packaging has been designed such that blister packs would have extra space for brand name which ensures easy identification at the pharmacy, a tab at the bottom with expiry date clearly mentioned, and a pictorial representation of the time the medicine needs to be taken.

Global expansion[ edit ] The company elected to expand globally, and acquired other entities.Corporate social responsibility (CSR) and sustainability data for Dr. Reddy's Laboratories Ltd., Pharmaceutical & Medicine Manufacturing and India.

Environment. INDEPENDENT AUDITORS' REPORT. TO THE MEMBERS OF DR.

REDDY'S LABORATORIES LIMITED. REPORT ON THE STANDALONE FINANCIAL STATEMENTS. We have audited the accompanying standalone financial statements. NAME AND TITLE OF INDIVIDUAL TO WHOM REPORT IS ISSUED TO: Dr. Sunil Bawane, Sr.

Dr. Reddy's Laboratories

Director & Site Head Manufacturing Dr. Reddy's Laboratories, Ltd. (Chemical Tech Ops -. Sales & Operations. Dr. Reddy’s is a generic medicine manufacturer founded inwith commercial presence in 26 countries.

Its core therapeutic areas include oncology, gastroenterology, cardiovascular health, diabetes and anti-infectives. See 34 recent research reports for DRREDDY, BSE Dr. Reddy's Laboratories Ltd. from 13 source(s) with an average target price of /5(34). © Dr.

Reddy’s Laboratories Ltd. All rights reserved.

Please read the legal notice for further details. Unless otherwise specified, all product and service.

Download
Report dr reddy s laboratories ltd
Rated 4/5 based on 87 review